Cited by 16Urinary Bladder and Prostate ResearchSpinal Cord Injury ResearchUrological Disorders and Treatments

Role of p38 MAP kinase signaling pathways in storage and voiding dysfunction in mice with spinal cord injury

Shimizu, Nobutaka, Wada, Naoki, Shimizu, Takahiro, Suzuki, Takahisa, Kurobe, Masahiro, Kanai, Anthony J., de Groat, William C., Hashimoto, Mamoru +3 more·2020·Neurourology and Urodynamics

Abstract

Aim: To investigate the role of p38 MAP kinase in lower urinary tract dysfunction in mice with spinal cord injury (SCI). Methods: Cystometry and external urethral sphincter‐electromyography were performed under an awake condition in 4‐week SCI female mice. Two weeks after SCI, a catheter connected to an osmotic pump filled with a p38 mitogen‐activated protein kinase (MAPK) inhibitor or artificial cerebrospinal fluid (CSF) was implanted into the intrathecal space of L6‐S1 spinal cord for continuous intrathecal instillation at infusion rate of 0.51 μL/h for 2 weeks before the urodynamic study. L6 dorsal root ganglia were then removed from CSF and p38 MAPK inhibitor‐treated SCI mice as well as from CSF‐treated normal (spinal intact) mice to evaluate the levels of transient receptor potential cation channel subfamily V member 1 (TRPV1), tumor necrosis factor‐α (TNF‐α), and inducible nitric oxide synthase (iNOS) transcripts by real‐time polymerase chain reaction. Results: In p38 MAPK inhibitor‐treated SCI mice, nonvoiding contractions during bladder filling, bladder capacity, and post‐void residual volume were significantly reduced while micturition pressure and voiding efficiency were significantly increased in comparison to these measurements in CSF‐treated SCI mice. The expression of TRPV1, TNF‐α, and iNOS messenger RNA was increased in SCI mice compared with expression in spinal intact mice and significantly decreased after p38 MAPK inhibitor treatment. Conclusions: The p38 MAPK signaling pathway in bladder sensory neurons or in the spinal cord plays an important role in storage and voiding problems such as detrusor overactivity and inefficient voiding after SCI.

Integrity signals

Registry

Crossref · 10.1002/nau.24170

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Telehealth can be appropriate and effective for overactive bladder follow-up and medication management.

    “overactive bladder follow-up and medication management”
  • Available data suggest that OAB care may be more cost-effective if the first visit is in person, while remote follow-up for first- and second-line therapy is probably safe and may enhance adherence and progression to third-line treatment.

    “The available data suggests that care may be more cost-effective when the initial consultation is in-person, but follow-up for first- and second-line therapy is likely safe and may improve adherence to care and progression to third-line treatment.”
  • For OAB/UUI, the first assessment may be more cost-effective in person, whereas later telehealth follow-up may improve medication adherence and increase progression to third-line treatment.

    “The initial evaluation of OAB/UUI may be more cost-effective when performed in person, but subsequent telehealth follow-up may improve adherence to medication management and increase rates of progression to third-line therapy.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shimizu, N., Wada, N., Shimizu, T., Suzuki, T., Kurobe, M., Kanai, A. J., de Groat, W. C., Hashimoto, M., Hirayama, A., Uemura, H., & Yoshimura, N.
Affiliations
  • University of Pittsburgh (US)
  • Department of Pharmacology and Chemical Biology University of Pittsburgh Pittsburgh Pennsylvania
  • Kindai University (JP)
  • Kindai University Nara Hospital (JP)
Corresponding author
Yoshimura, Naoki
Venue
Neurourology and Urodynamics
Publisher
Wiley
Published
2019-10-03
Volume
39
Issue
1
Pages
108-115
ISSN
  • 0733-2467 (ISSN-L)
  • 1520-6777
OpenAlex
W2751847595
Cited by
16
References
24
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 2
FWCI
1.60
Type
journal article
Language
en
Open access
closed
Locations
  • Neurourology and Urodynamics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense (W81XWH‐17‐1‐0403)
  • Foundation for the National Institutes of Health (NIH P01 DK093424)
Topics
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Spinal Cord Injury Research
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
Keywords
p38 MAPK, spinal cord injury, lower urinary tract dysfunction, voiding dysfunction, detrusor overactivity, dorsal root ganglia, TRPV1, TNF-α, inducible nitric oxide synthase, micturition pressure, post-void residual urine
MeSH terms
Animals, Urinary Bladder, Electromyography, Female, Mice, Inbred C57BL, Spinal Cord Injuries, Tumor Necrosis Factor-alpha, Urethra, Urination Disorders, Urodynamics, MAP Kinase Signaling System, Protein Kinase Inhibitors, p38 Mitogen-Activated Protein Kinases, TRPV Cation Channels, Mice, Nitric Oxide Synthase Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review